Concurrent Investment Advisors, LLC Bristol Myers Squibb CO Transaction History
Concurrent Investment Advisors, LLC
- $3.71 Trillion
- Q4 2024
A detailed history of Concurrent Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 5,000 shares of BMY stock, worth $299,100. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,000
Previous 28,164
82.25%
Holding current value
$299,100
Previous $1.46 Billion
80.59%
% of portfolio
0.01%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,760Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.49 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.74 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.69 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.61 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $127B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...